Su Won Lee (Su-Won Lee)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Chronic Obstructive Pulmonary Disease

Allergic Rhinitis

Top Venues

Healthcare (Basel, Switzerland)

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Su Won Lee, Seong-Cheon Woo, Yee Ran Lyu, Won-Kyung Yang, Seung-Hyung Kim, Je Hyun Kim, Si Yeon Kim, Weechang Kang, In-Chul Jung, Taesoo Kim, Yang-Chun Park
Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Randomized, Double-Blinded, Placebo-Controlled, Phase II Trial. Healthcare (Basel, Switzerland) 12 (10) (2024)
Su Won Lee, Seong-Cheon Woo, Yee Ran Lyu, Won-Kyung Yang, Seung-Hyung Kim, Je Hyun Kim, Si Yeon Kim, Weechang Kang, In-Chul Jung, Taesoo Kim, Yang-Chun Park
Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Randomized, Double-Blinded, Placebo-Controlled, Phase II Trial. Healthcare (Basel, Switzerland) 12 (10) (2024)
Su Won Lee, Seong-Cheon Woo, Yee Ran Lyu, Won-Kyung Yang, Seung-Hyung Kim, Je Hyun Kim, Si Yeon Kim, Weechang Kang, In-Chul Jung, Taesoo Kim, Yang-Chun Park
Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Randomized, Double-Blinded, Placebo-Controlled, Phase II Trial. Healthcare (Basel, Switzerland) 12 (10) (2024)
Yee Ran Lyu, Su Won Lee, Si Yeon Kim, Hye-Bin Han, Won-Kyung Yang, Seung-Hyung Kim, In-Chul Jung, O-Jin Kwon, Ae-Ran Kim, Jinhee Kim, Mee-Young Lee, Yang-Chun Park
Herbal Medicines for the Treatment of Chronic Obstructive Airway Diseases (Asthma or Chronic Obstructive Pulmonary Disease): A Prospective Observational Study. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Su Won Lee, Jin Kwan Choi, Yee Ran Lyu, Won-Kyung Yang, Seung-Hyung Kim, Je Hyun Kim, Si Yeon Kim, Weechang Kang, In-Chul Jung, Beom Joon Lee, Jun Yong Choi, Taesoo Kim, Yang-Chun Park
Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)